Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis

Archives of Gynecology and Obstetrics

Volumn 285, Issue 5, 2012, Pages 1307-1312

  Mabrouk, Mohamed ^a,b   Elmakky, Amira ^c   Caramelli, Elisabetta ^c   Farina, Antonio ^a   Mignemi, Giuseppe ^a   Venturoli, Stefano ^a   Villa, Gioia ^a   Guerrini, Manuela ^a   Manuzzi, Linda ^a   Montanari, Giulia ^a   De Sanctis, Paola ^c   Valvassori, Luisa ^c   Zucchini, Cinzia ^c   Seracchioli, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CA 125 and CA 19 9; Endometriosis; MMPs; Peripheral blood marker; Survivin

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; GELATINASE B; MESSENGER RNA; STROMELYSIN; SURVIVIN; VASCULOTROPIN; BIOLOGICAL MARKER; MOLECULAR MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP ENDOMETRIOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; FALSE POSITIVE RESULT; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MMP3 GENE; MMP9 GENE; MOLECULAR DIAGNOSIS; OVARY ENDOMETRIOSIS; SURVIVIN GENE; VEGF GENE; ADENOMYOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; ROC CURVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862757633     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2122-4     Document Type: Article

References (40)

1. Missmer SA, Cramer DW (2003) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 30(1):1-19
2. American Society for Reproductive Medicine (1997) Revised classification of endometriosis. Fertil Steril 67:817-821
3. Chapron C, Fauconnier A, Vieira M et al (2003) Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod 18(1):157-161 (Pubitemid 36138869)
4. Royal College of Obstetrics and Gynaecology (2006) The investigation and management of endometriosis. Green-top guideline no 24. RCOG, London
5. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG (2007) Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod 22(1):266-271 (Pubitemid 44942695)
6. Koninckx PR, Martin D (1994) Treatment of deeply infiltrating endometriosis. Curr Opin Obstet Gynecol 6(3):231-241 (Pubitemid 24143960)
7. Abrao MS, Goncalves MO, Dias JA Jr, Podgaec S, Chamie LP, Blasbalg R (2007) Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 22(12):3092-3097 (Pubitemid 351696760)
8. Chapron C, Chopin N, Borghese B, Malartic C, Decuypere F, Foulot H (2004) Surgical management of deeply infiltrating endometriosis: an update. Ann NY Acad Sci 1034:326-337 (Pubitemid 40362371)
9. Attaran M, Falcone T, Goldberg J (2002) Endometriosis: still tough to diagnose and treat. Clevel Clin J Med 69(8):647-653 (Pubitemid 34947060)
10. Harkki-Siren P, Sjoberg J, Kurki T (1999) Major complications of laparoscopy: a follow-up Finnish study. Obstet Gynecol 94:94-98 (Pubitemid 29284433)
11. Chapron C, Querleu D, Bruhat MA et al (1998) Surgical complications of diagnostic and operative gynaecological laparoscopy: a series of 29, 966 cases. Hum Reprod 13:867-872 (Pubitemid 28239189)
12. Osteen KG, Yeaman GR, Bruner-Tran KL (2003) Matrix metalloproteinase and endometriosis. Semin Reprod Med 21:155-164
13. Ueda M, Yamashita Y, Takehara M et al (2002) Survivin gene expression in endometriosis. J Clin Endocrinol Metab 87(7):3452-3459 (Pubitemid 34816403)
14. Ramon L, Gilabert-Estelles J, Castello R, Gilabert J, Espana F, Romeu A et al (2005) m RNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay. Hum Reprod 20:272-278
15. Bruner-tran KL, Eisenberg E, Yeaman GR, Anderson TA, Mc Bean J, Osteen KG (2002) Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishmentofexperimentalendometriosisinnudemice. JClin Endocrinol Metab 87:4782-4791 (Pubitemid 35247076)
16. Mulayim N, Savlu A, Guzeloglu-Kayisli O, Kayisli UA, Arici A (2004) Regulation of endometrial-stromal cell matrix metalloproteinase activity andinvasiveness byinterleukin-8. Fertil Steril 81:904-911 (Pubitemid 38333079)
17. Wu MH, Shoji Y, Wu MC et al (2005) Suppression of matrix metalloproteinase-9 by prostaglandin E2 in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 167:1061-1069 (Pubitemid 41416258)
18. Gilabert-Estelle's J, Ramo'n LA, España F et al (2007) Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 22:2120-2127 (Pubitemid 47241856)
19. Eel-D Othman, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A (2008) Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol Appl 137:240-246 (Pubitemid 351423457)
20. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M (2006) The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 132:501-509 (Pubitemid 44524514)
21. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L (2002) Expression of vascular endothelial growth factor and thrombospondin-1 m RNA in patients with endometriosis. Fertil Steril 78:148-153 (Pubitemid 34722685)
22. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M (2004) Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 35:1369-1375 (Pubitemid 39601577)
23. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C (2009) Metalloproteinases, vascular endothelial growth factor and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril 91:2315-2323
24. Machado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE (2008) Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 90:148-155 (Pubitemid 351885185)
25. Harada T, Kubota T, Aso T (2002)Usefulnessof CA19-9versus CA125 for the diagnosis of endometriosis. Fertil Steril 78:733-739
26. Mol BW, Bayram N, Lijmer JG et al (1998) The performance of CA-125 measurement in the detection of endometriosis: a metaanalysis. Fertil Steril 70:1101-1108 (Pubitemid 28546238)
27. Somigliana E, Vigano' P, Tirelli AS et al (2004) Use of the concomitantserumdosageof CA125, CA19-9andinterleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benigngynaecologicalconditions.Hum Reprod19(8):1871- 1876 (Pubitemid 39144638)
28. Kurdoglu Z, Gursoy R, Kurdoglu M, Erdem M, Erdem O, Erdem A (2009)Comparisonoftheclinicalvalueof CA19-9versus CA125 forthediagnosisofendometriosis.Fertil Steril92(5):1761-1763
29. Osteen KG, Bruner KL, Sharpe-Timms KL (1996) Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 14:247-255 (Pubitemid 126450924)
30. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B (2001) Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 95:167-174 (Pubitemid 32297710)
31. Gilabert-Estelle's J, Estelle's A, Gilabert J et al (2003) Expression of several components of the plasminogen activator and matrix metalloproteinas systems in endometriosis. Hum Reprod 18:1516-1522 (Pubitemid 36840963)
32. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M (2001) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 m RNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 75:152-159 (Pubitemid 32041238)
33. Li Y, Lang JH (2006) Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 m RNA in endometriosis. Zhonghua Fu Chan Ke Za Zhi 41:30-33
34. Ambrosini G, Adida C, Altieri DC (1999)A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921
35. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A (2000) Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 6:529-534 (Pubitemid 30365798)
36. Fujino K, Ueda M, Takehara M et al (2006) Transcriptional expression of survivin and its splice variants in endometriosis. Mol Hum Reprod 12(6):383-388 (Pubitemid 43985609)
37. Gagné D, Pagé M, Robitaille G, Hugo P, Gosselin D (2003) Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod 18:1674-1680 (Pubitemid 36958049)
38. Matalliotakis IM, Goumenou AG, Koumantakis GE et al (2003) Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol 3:81-89 (Pubitemid 36106453)
39. Oliveira VA, Abreu LG, Ferriani RA, Reis RM, Moura MD (2005) Vascular endothelial growth factor in the plasma, follicular fluid and granulosa cells of women with endometriosis submitted to in vitro fertilization-a pilot study. Gynecol Endocrinol 20:284-288 (Pubitemid 40897395)
40. Xavier P, Belo L, Beires J, Rebelo I, Martinez-de-Oliveira J, Lunet N, Barros H (2006)Serum levelsof VEGFand TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 273:227-231 (Pubitemid 43004695)